osemozotan has been researched along with 5-hydroxytryptophan in 1 studies
| Studies (osemozotan) | Trials (osemozotan) | Recent Studies (post-2010) (osemozotan) | Studies (5-hydroxytryptophan) | Trials (5-hydroxytryptophan) | Recent Studies (post-2010) (5-hydroxytryptophan) |
|---|---|---|---|---|---|
| 32 | 0 | 4 | 4,177 | 157 | 298 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, S; Kim, HS; Matsuda, T; Morita, T; Nakano, Y; Nakasu, Y; Somboonthum, P; Suzuki, M; Takuma, K; Yoshikawa, T | 1 |
1 other study(ies) available for osemozotan and 5-hydroxytryptophan
| Article | Year |
|---|---|
Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)amino]propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Brain; Dioxanes; Dioxoles; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Receptor Agonists | 1995 |